1-77942469-AGAGGAG-AGAG
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PM4_SupportingBP6BS2
The NM_144573.4(NEXN):c.1680_1682delGGA(p.Glu561del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,530 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E560E) has been classified as Likely benign.
Frequency
Consequence
NM_144573.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathy 1CCInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathy 20Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NEXN | NM_144573.4 | c.1680_1682delGGA | p.Glu561del | disruptive_inframe_deletion | Exon 13 of 13 | ENST00000334785.12 | NP_653174.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NEXN | ENST00000334785.12 | c.1680_1682delGGA | p.Glu561del | disruptive_inframe_deletion | Exon 13 of 13 | 1 | NM_144573.4 | ENSP00000333938.7 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152160Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000161 AC: 4AN: 248322 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461252Hom.: 0 AF XY: 0.0000193 AC XY: 14AN XY: 726946 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74476 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
The NEXN c.1680_1682del; p.Glu562del variant (rs397517848) is reported in the literature in an individual affected with dilated cardiomyopathy (Mazzarotto 2020). This variant is reported in ClinVar (Variation ID: 201945) and is found in the general population with an overall allele frequency of 0.0018% (5/279,708 alleles) in the Genome Aggregation Database. This variant deletes a single glutamate residue leaving the rest of the protein in-frame. Due to limited information, the clinical significance of this variant is uncertain at this time. References: Mazzarotto F et al. Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy. Circulation. 2020 Feb 4;141(5):387-398. PMID: 31983221. -
This variant is associated with the following publications: (PMID: 31983221) -
Dilated cardiomyopathy 1CC;C3151267:Hypertrophic cardiomyopathy 20 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 201945). This variant has not been reported in the literature in individuals affected with NEXN-related conditions. This variant is present in population databases (rs769530172, gnomAD 0.006%). This variant, c.1680_1682del, results in the deletion of 1 amino acid(s) of the NEXN protein (p.Glu562del), but otherwise preserves the integrity of the reading frame. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at